Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-30T00:01:52.167Z Has data issue: false hasContentIssue false

P-449 - Prognostic Factors Regarding the Treatment of Dementia Paralytica With Malaria Fever Therapy: a Historical Cohort Study

Published online by Cambridge University Press:  15 April 2020

I.M. Daey Ouwens
Affiliation:
Centre of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, The Netherlands
A.T.L. Fiolet
Affiliation:
Centre of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, The Netherlands
P.J.J. Koehler
Affiliation:
Neurology, Atrium Medical Centre, Heerlen, The Netherlands
A. Ott
Affiliation:
Laboratory for Infectious Diseases, Groningen, The Netherlands
W.M.A. Verhoeven
Affiliation:
Centre of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, The Netherlands Department of Psychiatry, Erasmus University Medical Centre, Venray, The Netherlands

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction:

Dementia paralytica, a late neuropsychiatric complication of syphilis, was common in Europe at the beginning of the 20th century. in the course of the subsequent century, the number of patients decreased dramatically, partly due to improved treatment options. One of the great therapeutic breakthroughs was the discovery of malaria fever therapy by Wagner von Jauregg.

Aim:

This retrospective cohort-study was designed to detect prognostic factors regarding the treatment of dementia paralytica with malaria fever therapy.

Methods:

Inpatients of the Vincent van Gogh psychiatric hospital in Venray were included in this study if they had a discharge diagnosis of dementia paralytica (general paralysis of the insane) and had been treated with malaria fever therapy in the period from 1907 to 1970. Patients were identified using annual reports and death registries from the hospital. Each patient's clinical record was reviewed for demographic, clinical, therapeutical and laboratory data. We measured survival after malaria fever therapy. Treatment response was categorized as: complete remission, incomplete remission but no hospitalization required, incomplete remission and permanent hospitalization required, unimproved or death during or shortly after treatment. the cause of death was classified as related or not related to dementia paralytica.

Results:

Preliminary results suggest that 70 % of the patients were male. Many patients died within 2 months of hospitalisation, but some survived for more than 20 years.

Conclusions:

Further analysis is currently being done and definite results and conclusions will be presented at the meeting.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.